Journey Medical Corporation
DERM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $56 | $79 | $74 | $63 |
| % Growth | -29.1% | 7.5% | 16.7% | – |
| Cost of Goods Sold | $21 | $27 | $31 | $32 |
| Gross Profit | $35 | $53 | $43 | $31 |
| % Margin | 62.8% | 66.3% | 58.2% | 49.2% |
| R&D Expenses | $10 | $8 | $11 | $17 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $40 | $44 | $59 | $40 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | $3 | $0 | $10 |
| Operating Expenses | $49 | $55 | $70 | $66 |
| Operating Income | -$14 | -$2 | -$28 | -$35 |
| % Margin | -24.4% | -2.6% | -37.4% | -55.2% |
| Other Income/Exp. Net | -$1 | -$2 | -$2 | -$7 |
| Pre-Tax Income | -$15 | -$4 | -$30 | -$42 |
| Tax Expense | $0 | $0 | $0 | $2 |
| Net Income | -$15 | -$4 | -$30 | -$44 |
| % Margin | -26.1% | -4.9% | -40.2% | -69.7% |
| EPS | -0.72 | -0.21 | -1.69 | -2.54 |
| % Growth | -242.9% | 87.6% | 33.5% | – |
| EPS Diluted | -0.72 | -0.21 | -1.69 | -2.54 |
| Weighted Avg Shares Out | 20 | 18 | 18 | 17 |
| Weighted Avg Shares Out Dil | 20 | 18 | 18 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $3 | $2 | $2 | $7 |
| Depreciation & Amortization | $4 | $4 | $4 | $3 |
| EBITDA | -$8 | $2 | -$23 | -$33 |
| % Margin | -15% | 2.4% | -31.5% | -51.9% |